With 16 cancer drugs on the FDA s drug shortage list, Jason Westin, MD, spoke to the Senate Finance Committee on behalf of the Association for Clinical Oncology.
Anne Klibanski, MD, CEO of Mass General Brigham, shares her reaction to Dana-Farber Cancer Institute s decision to partner with another health system for cancer